ASCENTAGE PHARMA GROUP INTERNATIONAL

Biopharma developing small-molecule drugs for cancer, HBV, and age-related diseases.

AAPG | NDAQ

Overview

Corporate Details

ISIN(s):: US04390B1052
LEI:
Country:: United States of America
Address:: 68 XINQING ROAD, 0 SUZHOU , JIANGSU
Website:: https://www.ascentage.cn/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Ascentage Pharma Group International is a global, clinical-stage biopharmaceutical company focused on developing novel therapies for cancers, chronic hepatitis B, and age-related diseases with unmet medical needs. The company's core R&D strategy targets apoptosis pathways, specializing in small-molecule drug candidates that inhibit protein-protein interactions. Its robust pipeline features potential first-in-class and best-in-class assets, including the approved third-generation BCR-ABL inhibitor olverembatinib and the Bcl-2 inhibitor lisaftoclax. With over 40 clinical trials active globally, Ascentage Pharma has secured numerous priority and orphan drug designations from the US FDA and China's CDE. The company actively pursues a global strategy through clinical and commercial collaborations with leading pharmaceutical companies and research institutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ASCENTAGE PHARMA GROUP INTERNATIONAL filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ASCENTAGE PHARMA GROUP INTERNATIONAL

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for ASCENTAGE PHARMA GROUP INTERNATIONAL via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Daesung Microbiological Labs. Co. Ltd Researches and manufactures veterinary vaccines and medicines for livestock, fish, and canines.	South Korea	036480
DAEWOONG PHARMA A global R&D partner for drug development, manufacturing, and commercialization services.	South Korea	069620
DAIICHI SANKYO COMPANY, LIMITED A global pharmaceutical firm developing novel therapies with a focus on oncology and ADCs.	Japan	4568
Daito Pharmaceutical Co., Ltd. Manufactures APIs, generic drugs, and health foods; provides contract manufacturing services.	Japan	4577
Dare Bioscience, Inc. Advancing innovative therapies for women's health in contraception, fertility, and sexual health.	United States of America	DARE
Day One Biopharmaceuticals, Inc. Developing targeted cancer therapies for all ages, with a focus on pediatric oncology.	United States of America	DAWN
DBV Technologies S.A. Developing non-invasive skin patch immunotherapies for food allergies and immune diseases.	United States of America	DBVT
D&D Pharmatech Inc. Develops oral & injectable peptide therapies for metabolic & chronic diseases like obesity.	South Korea	347850
Dechra Pharmaceuticals PLC Develops & sells veterinary pharmaceuticals for companion animals, exclusively to veterinarians.	United Kingdom	DPH
Denali Therapeutics Inc. Developing therapies for neurodegenerative diseases that cross the blood-brain barrier.	United States of America	DNLI